In late June 2025, a Daily Mail article highlighted the surging interest in ivermectin, an anti-parasitic drug, for potential cancer treatment, spurred by claims from actor Mel Gibson. On ”The Joe Rogan Experience” podcast, which garnered over 11 million YouTube views since January, Gibson stated that three friends with stage 4 cancer recovered after using ivermectin and other treatments. This has fueled public curiosity, with Google searches for ivermectin peaking in January 2025, the highest since the 2022 COVID wave. Research from 2024, cited by FirstMed Inc., shows ivermectin inhibiting bladder cancer cell proliferation by inducing oxidative stress and DNA damage, supporting its potential as a cytotoxic agent. Sixteen U.S. states, including Arkansas and Tennessee, have proposed or passed laws to make ivermectin available over the counter, though the FDA has not approved it for this use. In Louisiana, 40 oncologists urged against such legislation, citing risks. The drug, discovered in the 1970s and Nobel Prize-winning in 2015 for parasitic treatments, remains under scrutiny for broader applications.
34news.online
34news.online
